EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Desmosomal Versus Non-Desmosomal Arrhythmogenic Cardiomyopathies: A State-of-the-Art Review

Kristian Galanti, Lorena Iezzi, Maria Luana Rizzuto, Daniele Falco, Giada Negri, Hoang Nhat Pham, Davide Mansour, Roberta Giansante, Liborio Stuppia, Lorenzo Mazzocchetti, Sabina Gallina, Cesare Mantini und 3 weitere

Cardiogenetics · 01.08.2025 · 15 (3) · 22

DOI: 10.3390/cardiogenetics15030022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiogenetics, online erschienen am 01.08.2025. Verfasst von Kristian Galanti und 14 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Society of Cardiology, European Union—Next-Generation EU, Italian Ministry of University and Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arrhythmogenic cardiomyopathies (ACMs) are a phenotypically and etiologically heterogeneous group of myocardial disorders characterized by fibrotic or fibro-fatty replacement of ventricular myocardium, electrical instability, and an elevated risk of sudden cardiac death. Initially identified as a right ventricular disease, ACMs are now recognized to include biventricular and left-dominant forms. Genetic causes account for a substantial proportion of cases and include desmosomal variants, non-desmosomal variants, and familial gene-elusive forms with no identifiable pathogenic mutation. Nongenetic etiologies, including post-inflammatory, autoimmune, and infiltrative mechanisms, may mimic the phenotype. In many patients, the disease remains idiopathic despite comprehensive evaluation. Cardiac magnetic resonance imaging has emerged as a key tool for identifying non-ischemic scar patterns and for distinguishing arrhythmogenic phenotypes from other cardiomyopathies. Emerging classifications propose the unifying concept of scarring cardiomyopathies based on shared structural substrates, although global consensus is evolving. Risk stratification remains challenging, particularly in patients without overt systolic dysfunction or identifiable genetic markers. Advances in tissue phenotyping, multi-omics, and artificial intelligence hold promise for improved prognostic assessment and individualized therapy.

Förderung

  • Italian Society of Cardiology
  • European Union—Next-Generation EU
  • Italian Ministry of University and Research

Zitieren

APA

Galanti, K., Iezzi, L., Rizzuto, M. L., Falco, D., Negri, G., Pham, H. N., Mansour, D., Giansante, R., Stuppia, L., Mazzocchetti, L., Gallina, S., Mantini, C., Khanji, M. Y., Chahal, C. A. A., & Ricci, F. (2025). Desmosomal Versus Non-Desmosomal Arrhythmogenic Cardiomyopathies: A State-of-the-Art Review. Cardiogenetics, 15(3), 22. https://doi.org/10.3390/cardiogenetics15030022

Vancouver

Galanti K, Iezzi L, Rizzuto ML, Falco D, Negri G, Pham HN, et al. Desmosomal Versus Non-Desmosomal Arrhythmogenic Cardiomyopathies: A State-of-the-Art Review. Cardiogenetics. 2025;15(3):22. doi:10.3390/cardiogenetics15030022

BibTeX
@article{Galanti2025,
  author = {Galanti, Kristian and Iezzi, Lorena and Rizzuto, Maria Luana and Falco, Daniele and Negri, Giada and Pham, Hoang Nhat and Mansour, Davide and Giansante, Roberta and Stuppia, Liborio and Mazzocchetti, Lorenzo and Gallina, Sabina and Mantini, Cesare and Khanji, Mohammed Y. and Chahal, C. Anwar A. and Ricci, Fabrizio},
  title = {Desmosomal Versus Non-Desmosomal Arrhythmogenic Cardiomyopathies: A State-of-the-Art Review},
  journal = {Cardiogenetics},
  year = {2025},
  volume = {15},
  number = {3},
  pages = {22},
  doi = {10.3390/cardiogenetics15030022}
}
Kostenlos starten →